CHRS
Coherus BioSciences Inc
Price:  
1.91 
USD
Volume:  
1,438,498.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS WACC - Weighted Average Cost of Capital

The WACC of Coherus BioSciences Inc (CHRS) is 8.2%.

The Cost of Equity of Coherus BioSciences Inc (CHRS) is 10.05%.
The Cost of Debt of Coherus BioSciences Inc (CHRS) is 7.35%.

Range Selected
Cost of equity 7.70% - 12.40% 10.05%
Tax rate 0.10% - 1.10% 0.60%
Cost of debt 7.00% - 7.70% 7.35%
WACC 7.2% - 9.1% 8.2%
WACC

CHRS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 1.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 12.40%
Tax rate 0.10% 1.10%
Debt/Equity ratio 2.17 2.17
Cost of debt 7.00% 7.70%
After-tax WACC 7.2% 9.1%
Selected WACC 8.2%